HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suresh C Tyagi Selected Research

Stroke (Strokes)

8/2013Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.
12/2012Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
12/2008Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
1/2005Homocysteine in microvascular endothelial cell barrier permeability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suresh C Tyagi Research Topics

Disease

67Hyperhomocysteinemia
02/2021 - 01/2003
33Heart Failure
04/2023 - 08/2002
29Inflammation (Inflammations)
12/2022 - 12/2007
27Fibrosis (Cirrhosis)
12/2022 - 05/2005
23Hypertension (High Blood Pressure)
04/2023 - 10/2004
15Vascular Remodeling
01/2018 - 05/2002
13Type 2 Diabetes Mellitus (MODY)
10/2022 - 07/2002
11Cardiovascular Diseases (Cardiovascular Disease)
03/2017 - 05/2004
9Atherosclerosis
09/2019 - 02/2004
8Myocardial Infarction
04/2023 - 06/2004
8Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 07/2002
7Hypertrophy
04/2023 - 11/2006
7Ischemia
10/2019 - 02/2007
7Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 04/2008
6Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2005
6Cardiomyopathies (Cardiomyopathy)
08/2015 - 01/2002
6Cardiomegaly (Heart Hypertrophy)
01/2014 - 05/2005
6Diabetes Mellitus
07/2006 - 01/2003
5COVID-19
01/2023 - 04/2021
5Obesity
02/2021 - 05/2005
5Reperfusion Injury
10/2019 - 01/2012
5Muscular Diseases (Myopathy)
06/2019 - 02/2009
5Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2016 - 10/2006
5Body Weight (Weight, Body)
02/2016 - 01/2011
5Atherosclerotic Plaque (Atheroma)
01/2016 - 02/2003
5Heart Diseases (Heart Disease)
04/2014 - 04/2009
5Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2012 - 01/2005
4Atrophy
11/2019 - 09/2017
4Hypoxia (Hypoxemia)
01/2018 - 03/2007
4Diabetic Cardiomyopathies
01/2016 - 09/2010
4Stroke (Strokes)
08/2013 - 01/2005
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2012 - 03/2006
4Cardiac Arrhythmias (Arrythmia)
01/2011 - 11/2007
3Insulin Resistance
10/2022 - 07/2002
3Macular Degeneration (Age-Related Maculopathy)
02/2021 - 01/2017
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2021 - 01/2017
3Dysbiosis
01/2021 - 01/2020
3Muscular Atrophy (Muscle Atrophy)
11/2019 - 04/2014
3Hyperglycemia
10/2019 - 12/2005
3Osteoporosis
01/2018 - 01/2011
3Cognitive Dysfunction
01/2018 - 09/2014
3Neoplasms (Cancer)
11/2017 - 03/2005
3Infarction (Infarctions)
07/2015 - 11/2010
3Hearing Loss (Hearing Impairment)
07/2015 - 12/2009
3Aortic Valve Stenosis (Aortic Stenosis)
05/2010 - 05/2007
3Diabetes Complications
08/2008 - 12/2004
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2008 - 02/2002
2Muscular Dystrophies (Muscular Dystrophy)
11/2023 - 09/2011
2Thromboembolism
01/2023 - 01/2018
2Glaucoma
02/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

76HomocysteineIBA
02/2021 - 05/2002
49Matrix Metalloproteinases (MMPs)IBA
11/2023 - 02/2002
26CollagenIBA
12/2022 - 01/2002
19Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2002
18Hydrogen Sulfide (Sulfide, Hydrogen)IBA
02/2021 - 08/2009
16Folic Acid (Vitamin M)FDA LinkGeneric
12/2021 - 02/2003
13Metalloproteases (Metalloproteinases)IBA
01/2023 - 01/2002
12MicroRNAs (MicroRNA)IBA
10/2022 - 01/2009
11AntioxidantsIBA
04/2021 - 10/2004
10ElastinIBA
12/2022 - 09/2003
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 07/2002
9PPAR gammaIBA
07/2014 - 03/2005
8EnzymesIBA
01/2023 - 04/2009
8Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2022 - 12/2005
8Methionine (L-Methionine)FDA Link
02/2021 - 01/2013
7CytokinesIBA
12/2022 - 01/2014
7Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2017 - 01/2003
7Tissue Inhibitor of MetalloproteinasesIBA
01/2017 - 09/2003
6CystathionineIBA
11/2018 - 01/2011
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2018 - 05/2002
5CarbonIBA
11/2023 - 01/2018
5Glucose (Dextrose)FDA LinkGeneric
10/2022 - 12/2004
5Toll-Like Receptor 4IBA
11/2017 - 10/2016
5Fibrinogen (Factor I)FDA Link
07/2017 - 01/2008
5salicylhydroxamic acid (SHAM)IBA
07/2017 - 04/2002
5Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
01/2013 - 02/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 02/2009
4Retinaldehyde (Retinal)IBA
02/2021 - 01/2018
4CalciumIBA
04/2019 - 03/2005
4sodium bisulfide (NaHS)IBA
01/2019 - 01/2009
4Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2008
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2016 - 03/2009
4ConnexinsIBA
09/2015 - 08/2002
4Tissue Inhibitor of Metalloproteinase-3IBA
01/2012 - 05/2010
43-nitrotyrosineIBA
01/2009 - 08/2002
3SaltsIBA
04/2023 - 12/2008
3MethyltransferasesIBA
02/2021 - 02/2014
3Amino AcidsFDA Link
01/2019 - 01/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 03/2007
3N-Methylaspartate (NMDA)IBA
04/2014 - 04/2008
3Messenger RNA (mRNA)IBA
01/2014 - 04/2002
3IntegrinsIBA
02/2010 - 08/2002
3ciglitazoneIBA
11/2008 - 09/2007
2SARS-CoV-2 spike proteinIBA
01/2023 - 01/2023
2Angiotensin-Converting Enzyme 2IBA
01/2023 - 01/2023
2Blood Glucose (Blood Sugar)IBA
10/2022 - 01/2015
2Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 09/2004
2AcidsIBA
04/2021 - 06/2008
2Doxycycline (Periostat)FDA LinkGeneric
04/2021 - 06/2004

Therapy/Procedure

7Therapeutics
01/2023 - 02/2003